Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MerLion Pharmaceuticals claims new macrolides

June 17, 2010

COMP recommends orphan drug status for 2B3-101 in glioma

June 16, 2010

Celsion to report on phase I/II DIGNITY trial in recurrent chest wall breast cancer

June 16, 2010

Interim phase II data disclosed on PF-00299804 in recurrent/metastatic SCCHN

June 16, 2010

Safety and preliminary antitumor activity of OSI-027 seen in ongoing first-in-man trial

June 16, 2010

Mikana Therapeutics presents new protein kinase inhibitors

June 16, 2010

Novel autotaxin inhibitors identified by Merck KGaA

June 16, 2010

Phase III NExUS trial of sorafenib in NSCLC does not meet primary endpoint

June 15, 2010

Telormedix begins phase I/II TMX-101 trial in non-muscle-invasive bladder cancer

June 15, 2010

R-7160 evaluated in phase I/II trial in solid tumors

June 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026